3

OWNERSHIP DOCUMENT

Company: Amneal Pharmaceuticals, Inc.
Filed: July 19, 2019
Period of Report: July 18, 2019
Accession Number: 0001387131-19-005208

View Document ↗ View on SEC.gov ↗